Sustainability, Culture & Acquisitions with Professor Hanns-Christian Mahler, CEO at ten23 health
Thu Jan 22 2026
In this episode, hear from Professor Hanns-Christian Mahler, a visionary in pharmaceutical innovation and culture building. As CEO, Chief Enablement Officer, and Board Member of ten23 health, he’s redefining what it means to lead with purpose in the life sciences sector.
With a career spanning Merck KGaA, Roche, and Lonza, alongside academic roles at the University of Basel and Frankfurt am Main, Dr. Mahler brings a rare blend of scientific rigour, entrepreneurial drive, and human-centred leadership.
At ten23 health, the mission goes beyond developing pharmaceutical solutions; it’s about building a company where sustainability, culture, and mindset are as integral as technical excellence.
Discussions in the episode:
The inspiration behind founding ten23 health and the standout chapters of growth so farEmbedding sustainability as a core mindset, not just a checkboxLessons learned and challenges navigating acquisitionsBalancing human creativity with technology to shape the future of pharmaceutical innovation.
Click here to reach out to Peter Rabey direct
Like this show? Please leave us a review. Every review helps.
More
In this episode, hear from Professor Hanns-Christian Mahler, a visionary in pharmaceutical innovation and culture building. As CEO, Chief Enablement Officer, and Board Member of ten23 health, he’s redefining what it means to lead with purpose in the life sciences sector. With a career spanning Merck KGaA, Roche, and Lonza, alongside academic roles at the University of Basel and Frankfurt am Main, Dr. Mahler brings a rare blend of scientific rigour, entrepreneurial drive, and human-centred leadership. At ten23 health, the mission goes beyond developing pharmaceutical solutions; it’s about building a company where sustainability, culture, and mindset are as integral as technical excellence. Discussions in the episode: The inspiration behind founding ten23 health and the standout chapters of growth so farEmbedding sustainability as a core mindset, not just a checkboxLessons learned and challenges navigating acquisitionsBalancing human creativity with technology to shape the future of pharmaceutical innovation. Click here to reach out to Peter Rabey direct Like this show? Please leave us a review. Every review helps.